Source: ERS Research Seminar



Rating:

Share or cite this content

Citations should be made in the following way:
Nicolas Girard (Lyon, France). Target amplification/protein surexpression: c met and FGFR. ERS Research Seminar

Member's Comments

No comment yet.

Related content which might interest you: Microbiote et cancer bronchique: l'exemple de l'immunothérapie / Microbiota and lung cancer: an example of immunotherapy Source: Virtual Congress 2021 – French programme 2021 Year: 2021 Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last ! Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020 Target other gene point mutations: HER2 and rare EGFR mutations Source: ERS Research Seminar Year: 2015 La thermoplastie dans l’asthme : corrélation clinique et histopathologiqueAsthma thermoplasty: clinical and histopathological correlation Source: International Congress 2017 – French Programme 2017 Year: 2017 Régulation de l'inflammation dans l'asthme : IL37 vs IL17Inflammatory regulation in asthma: IL37 vs IL17 Source: International Congress 2017 – French Programme 2017 Year: 2017 European mapping of EGFR mutation test and EGFR tyrosine kinase inhibitors availability in thoracic oncology Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Prise en charge de l’emphysème : Approche personnalisée / Management of emphysema: personalised approach Source: Virtual Congress 2021 – French programme 2021 Year: 2021 Target gene rearrangements: ALK, ROS and RET Source: ERS Research Seminar Year: 2015 La diffusion pulmonaire du monoxyde d’azote (DLNO): des recommandations pratiques aux applications cliniquesLung transfer of Nitric Oxide (DLNO): from practical guidelines to clinical applications Source: International Congress 2016 – ERS/French Programme II Year: 2016 A detailed immunohistochemical analysis of PI3K/AKT/MTOR pathway in lung cancer: Correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Troubles respiratoires du sommeil et cancer : données épidémiologiques / Respiratory disorders associated with sleep and cancer: epidemiological data Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020 Asthma in children: an updateAsma nel bambino: un update  Source: International Congress 2017 – ERS Italian Day programme Year: 2017 Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment Source: International Congress 2016 – ERS/French Programme I Year: 2016 Médecine personnalisée et BPCO: où en sommes-nous ?Personalised medicine and COPD: where are we now? Source: International Congress 2016 – ERS/French Programme I Year: 2016 The diagnosis and incidence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation in lung adenocarcinoma Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done? Source: Virtual Congress 2021 – French programme 2021 Year: 2021 COPD: the Italian recommendationBPCO: le raccomandazioni Italiane Source: International Congress 2017 – ERS Italian Day programme Year: 2017 Late Breaking Abstract: Real-time PCR versus direct sequencing in detection of EGFR T790M and L858R mutations – The sensitivity comparison Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010